Adverse events should be reported.

 This medicinal product is subject to additional monitoring and it is therefore important to report any suspected adverse events related to this medicinal product.  Reporting forms and information can be found at

Adverse events should also be reported to Janssen-Cilag Ltd on 01494 567447 or at [email protected].


Content Date of Preparation: March 2017
Item Code: PHGB/NPR/0317/0006a